Control and duration of therapy in complicated UTI--with special consideration of C-reactive protein.
Höffler
D
D
Klinik III, Städtische Kliniken, Darmstadt, Germany.
D000583:Amikacin / Q000627:therapeutic use*; D002097:C-Reactive Protein / Q000032:analysis / Q000378:metabolism*; D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D004926:Escherichia coli / Q000302:isolation & purification; D005260:Female; D006801:Humans; D008802:Mezlocillin / Q000627:therapeutic use*; D008875:Middle Aged; D014552:Urinary Tract Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy*
D000583:Amikacin; D002097:C-Reactive Protein; D008802:Mezlocillin